Now a day, the COX-II theory is established. What about the selectivity of Rheumarene (Diclofenac Sodium) for COX-II enzyme?
Diclofenac is (non selective) NSAIDs otherwise it’s most selective for COX-II than COX-I among the classical (non selective) NSAIDs. Therefore this is reflected on Rheumarene safety profile, ensures minimal adverse effects with patients and lowers discontinuation rate that helps physicians to gain more successful cure rates.
